Arctic Bioscience Balance Sheet Health
Financial Health criteria checks 5/6
Arctic Bioscience has a total shareholder equity of NOK258.6M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK300.3M and NOK41.7M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr79.60m |
| Equity | kr258.56m |
| Total liabilities | kr41.69m |
| Total assets | kr300.25m |
Financial Position Analysis
Short Term Liabilities: ABS's short term assets (NOK133.2M) exceed its short term liabilities (NOK39.6M).
Long Term Liabilities: ABS's short term assets (NOK133.2M) exceed its long term liabilities (NOK2.0M).
Debt to Equity History and Analysis
Debt Level: ABS is debt free.
Reducing Debt: ABS has no debt compared to 5 years ago when its debt to equity ratio was 55.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ABS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ABS has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 18.2% each year.